<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Bis(7)-<z:chebi fb="0" ids="45980">tacrine</z:chebi>, a promising anti-Alzheimer's dimer, has been shown to have multiple neuroprotective activities in vitro </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we investigate whether bis(7)-<z:chebi fb="0" ids="45980">tacrine</z:chebi> attenuates focal cerebral ischemic impairment in vivo </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0002637'>Cerebral ischemia</z:hpo> was induced in Sprague-Dawley rats by transient (2h) middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) followed by 24h of reperfusion </plain></SENT>
<SENT sid="3" pm="."><plain>Bis(7)-<z:chebi fb="0" ids="45980">tacrine</z:chebi> administered intraperitoneally 15 min after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> dose-dependently improved neurological behavior deficits and reduced both cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and <z:hpo ids='HP_0000969'>edema</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The TUNEL staining assay showed that bis(7)-<z:chebi fb="0" ids="45980">tacrine</z:chebi> attenuated neuronal <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in the penumbral region </plain></SENT>
<SENT sid="5" pm="."><plain>Compared with that for memantine, a moderately effective N-<z:chebi fb="36" ids="29309">methyl</z:chebi>-d-<z:chebi fb="0" ids="29995">aspartate</z:chebi> (<z:chebi fb="0" ids="31882">NMDA</z:chebi>) receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> with a similar affinity and potency to bis(7)-<z:chebi fb="0" ids="45980">tacrine</z:chebi> in blocking <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptors, the therapeutic window for bis(7)-<z:chebi fb="0" ids="45980">tacrine</z:chebi> was wider and lasted up to 6h after the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Bis(7)-<z:chebi fb="0" ids="45980">tacrine</z:chebi> did not affect physiological parameters or regional cerebral blood flow during either the occlusion period or the early reperfusion stage </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, bis(7)-<z:chebi fb="0" ids="45980">tacrine</z:chebi> dose- and time-dependently protected against <z:hpo ids='HP_0011009'>acute</z:hpo> focal cerebral ischemic insults, possibly through the drug's anti-apoptotic effects during multiple events in the ischemic cascade </plain></SENT>
</text></document>